Thornmark Asset Management’s Quest Diagnostics DGX Stock Holding History

Thornmark Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$1.13M	Sell	16,790 -4,330	-21%	-$273K	3.36%	8
2014 Q3	$1.28M	Hold	21,120	–	–	3.3%	12
2014 Q2	$1.24M	Buy	21,120 +5,200	+33%	+$305K	3.02%	14
2014 Q1	$922K	Buy	15,920 +8,310	+109%	+$445K	2.5%	17
2013 Q4	$407K	Hold	7,610	–	–	1.12%	37
2013 Q3	$470K	Sell	7,610 -34,590	-82%	-$2.07M	1.35%	34
2013 Q2	$2.56M	Buy	+42,200	New	+$2.51M	2.58%	21

Other funds holding DGX

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Thornmark Asset Management's DGX Position: Q4 2014 in Review

Thornmark Asset Management reduced its Quest Diagnostics (DGX) stake by 21% in Q4 2014, selling an estimated $273K and leaving 16,790 shares worth $1.13M. The position accounts for 3.36% of the portfolio, ranked #8.

Thornmark Asset Management first reported a position in DGX in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.56M in Q2 2013. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

Thornmark Asset Management held 16,790 shares of Quest Diagnostics worth $1.13M as of Q4 2014.
Thornmark Asset Management sold 4,330 Quest Diagnostics shares in Q4 2014, an estimated $273K.
Quest Diagnostics made up 3.36% of Thornmark Asset Management's portfolio in Q4 2014, its #8 holding.
Thornmark Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 7 quarters since.
Thornmark Asset Management's Quest Diagnostics position peaked at $2.56M in Q2 2013.
517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Thornmark Asset Management's 13F filing for Q4 2014, filed 6 Jan 2015.